Prophylaxis and treatment options for bacterial and fungal infections in recipients of hematopoietic stem cell transplantation: Brief review

Denis Sunay Niyazi 1, 2, *

1 Laboratory of Clinical Microbiology, University Hospital “St. Marina” – Varna, Varna, Bulgaria;
2 Department of Microbiology and Virology, Medical University - Varna, Varna, Bulgaria.
 
Review Article
GSC Biological and Pharmaceutical Sciences, 2023, 22(01), 186-196.
Article DOI: 10.30574/gscbps.2023.22.1.0024
Publication history: 
Received on 06 December 2022; revised on 14 January 2023; accepted on 17 January 2023
 
Abstract: 
Patients after hematopoietic stem cell transplantation are a risk group for developing various complications. Most of them are caused by infectious agents. Important in the post-transplant period is the prevention and therapy of these infectious complications, which often lead to high morbidity and mortality rates. The aim of this review is to present briefly the options for prevention and therapy of bacterial and mycotic infectious complications in these patients following hematopoietic stem cell transplantation.
 
Keywords: 
Hematopoietic stem cell transplantation; Bacteria; Fungi; Prophylaxis; Therapy
 
Full text article in PDF: 
Share this